Fresenius Medical Care North America Announces New Director of Nursing, Director of Transplant Medicine and Director of Medical Information

WALTHAM, Mass., September 29, 2021 / PRNewswire / – Fresenius Medical Care North America (FMCNA), the leading national provider of kidney care products and services, announced three key clinical leadership appointments to help set priorities, including improving outcomes for patients patients, adoption of connected health technologies to support home dialysis, and improved access to transplantation.

Kathleen belmonte was appointed Chief Nursing Officer and Senior Vice President of Clinical Services at Fresenius Kidney Care, the dialysis services division of FMCNA; Dr. Benjamin Hippen has been appointed Senior Vice President and Chief Transplant Medicine within the World Medical Bureau leadership team; Dr. Shelly nash has been appointed Senior Vice President and Chief Medical Officer of FMCNA.

“We welcome these exceptional clinical leaders who bring many years of in-depth experience both inside and outside our company,” said Bill Valle, CEO, FMCNA. “These people will help us continue to be the leader in value-based care and transform models of kidney care that slow disease progression, while improving dialysis and home transplant rates, clinical quality and information technology to improve experiences and affordability for the benefit of employees, physician partners, payers and, most importantly, our patients. “

In his new role as Chief Nursing Officer, Belmonte will lead efforts to ensure the delivery of high-quality clinical care at every step of the renal care continuum, while supporting the clinical professionals who make up patient care teams by overseeing career advancement opportunities. Belmonte continues to play a pivotal role during the COVID-19 pandemic, implementing new policies and procedures during an unprecedented time and leading the rollout of the vaccine at Fresenius Kidney Care clinics nationwide. Belmonte has also shown leadership on new protocols to improve transplant referrals and waitlist management.

As Senior Vice President and Chief of Transplant Medicine, another new role at Fresenius Medical Care, Dr. Hippen will lead the company’s efforts to expand access to and understanding of transplant medicine as a essential part of its patient-centered mission. Dr Hippen extends his long-standing relationship with Fresenius Medical Care and brings with him over 15 years of experience as a general nephrologist and transplant specialist and medical practitioner. He was also the medical director of a large center-based dialysis facility and a large home therapy unit.

Appointed Senior Vice President and Chief Medical Information Officer for FMCNA, Dr Nash will be responsible for ensuring seamless communication between clinical departments and information technology – a critical part of our ability to provide the best possible care. survival to patients. Dr Nash joins us at a critical time as connected health solutions have evolved from an emerging technology to something that can be relied on to provide safe care. Dr. Nash previously held a similar role for AdventHealth as vice president and chief medical officer and head of the Quality Physicians business.

“This expansion of our leadership team underscores our commitment to improving patient outcomes globally by recognizing the new leadership capabilities needed in the business,” said Dr. Franklin W. Maddux, Global Chief Medical Officer of Fresenius Medical Care. “Under their leadership in nursing, health information technology and organ transplantation, we will continue to foster innovation, expertise and credibility that will enhance our ability to provide innovative and holistic care. of the highest quality.

To learn more about the FMCNA and its leadership, please visit fmcna.com/company/.

About Fresenius Medical Care North America
Fresenius Medical Care North America (FMCNA) is the premier healthcare company focused on providing the highest quality care to people with kidney disease and other chronic conditions. Through its leading network of dialysis facilities and ambulatory cardiac and vascular laboratories, Fresenius Medical Care North America provides coordinated health services at essential points of care to hundreds of thousands of chronically ill clients across the continent. . As the world’s largest fully integrated renal company, it provides specialized pharmacy and laboratory services, and manufactures and distributes the most comprehensive line of dialysis equipment, disposables and renal pharmaceuticals. For more information, visit the FMCNA website at https://fmcna.com/.

Media contact:

Fresenius Medical Care North America
Brad puffer
Business communication
[email protected]
(781) 699-3331

SOURCE Fresenius Medical Care Holdings, Inc.

Related links

https://fmcna.com


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *